Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials

Contraception. 2007 Jul;76(1):53-6. doi: 10.1016/j.contraception.2006.10.012. Epub 2007 May 11.

Abstract

Introduction: Participant's adherence to use of study product is a major concern in microbicide clinical trials, which can impact on proving product efficacy. In a previously described assay, single-use microbicide applicators exposed to the vagina were tested by spraying the applicator with trypan blue dye, resulting in vaginal mucus staining on inserted applicators. As subjects in our Phase 3 trials return applicators only at quarterly visits, often mixing inserted and not-inserted applicators together in the same bag, cross-contamination could confound results. In addition, trypan blue is carcinogenic and thus potentially hazardous to technicians spraying daily.

Methods: Applicators that were exposed to the vagina were placed in the same bag as unexposed applicators and shaken daily for up to 4 months. Validation was carried out in three clinical sites in South Africa.

Results: Trypan blue was replaced with FD&C Blue #1 granular food dye. Cross-contamination did not occur, nor did the length of time affect reaction to dye. In South Africa, the assay was validated with an accuracy of over 95%.

Conclusion: Applicator assay modifications render the test safe and suitable for use in clinical trials.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Validation Study

MeSH terms

  • Administration, Intravaginal
  • Anti-Infective Agents / administration & dosage*
  • Clinical Trials as Topic
  • Coloring Agents
  • Drug Delivery Systems / instrumentation*
  • Equipment Contamination
  • Equipment Design
  • Female
  • Humans
  • New York
  • Patient Compliance*
  • Trypan Blue

Substances

  • Anti-Infective Agents
  • Coloring Agents
  • Trypan Blue